Key Points
- Paysign EVP Joan Herman sold 21,004 shares at an average price of $12.38, generating approximately $260,030. The transaction, conducted under a pre-arranged Rule 10b5-1 plan, reduced her holdings by 3.14% to 648,321 shares.
- Paysign exceeded quarterly expectations, reporting $0.11 in EPS versus the $0.06 consensus estimate and revenue of $28.25 million. The company guided for fiscal 2026 EPS of $0.350 to $0.370.
- Analysts remain positive, with Paysign holding a consensus “Buy” rating and a $14.00 target price. The stock recently traded near $12.42, compared with a 52-week range of $3.08 to $14.43.
Paysign, Inc. (NASDAQ:PAYS - Get Free Report) EVP Joan Herman sold 21,004 shares of the business's stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $12.38, for a total value of $260,029.52. Following the completion of the sale, the executive vice president owned 648,321 shares of the company's stock, valued at $8,026,213.98. The trade was a 3.14% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Paysign Stock Performance
NASDAQ:PAYS opened at $12.42 on Friday. Paysign, Inc. has a fifty-two week low of $3.08 and a fifty-two week high of $14.43. The firm has a market cap of $701.23 million, a PE ratio of 47.77 and a beta of 0.80. The business has a 50 day moving average price of $11.46 and a 200-day moving average price of $8.01.
Paysign (NASDAQ:PAYS - Get Free Report) last issued its earnings results on Wednesday, August 5th. The company reported $0.11 EPS for the quarter, topping the consensus estimate of $0.06 by $0.05. Paysign had a net margin of 15.67% and a return on equity of 30.13%. The company had revenue of $28.25 million for the quarter, compared to the consensus estimate of $26.36 million. Paysign has set its FY 2026 guidance at 0.350-0.370 EPS and its Q3 2026 guidance at 0.090-0.100 EPS. Research analysts predict that Paysign, Inc. will post 0.58 EPS for the current year.
Hedge Funds Weigh In On Paysign
A number of hedge funds have recently modified their holdings of the company. Legal & General Group Plc purchased a new position in shares of Paysign during the 2nd quarter valued at $35,000. Caitong International Asset Management Co. Ltd increased its stake in Paysign by 381.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 9,876 shares of the company's stock worth $51,000 after buying an additional 7,825 shares in the last quarter. EFG International AG purchased a new stake in Paysign in the 2nd quarter worth $68,000. Quantbot Technologies LP bought a new stake in Paysign during the second quarter valued at about $97,000. Finally, The Manufacturers Life Insurance Company purchased a new position in shares of Paysign in the second quarter valued at about $100,000. 25.89% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on PAYS shares. DA Davidson increased their target price on Paysign from $9.00 to $12.00 and gave the stock a "buy" rating in a research note on Thursday, August 6th. Weiss Ratings raised Paysign from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Wednesday, July 29th. Wall Street Zen lowered shares of Paysign from a "strong-buy" rating to a "buy" rating in a research note on Sunday, August 16th. Barrington Research set a $15.00 price objective on shares of Paysign in a research report on Tuesday, August 11th. Finally, Lake Street Capital boosted their target price on shares of Paysign from $13.00 to $15.00 and gave the company a "buy" rating in a research note on Tuesday. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Paysign presently has a consensus rating of "Buy" and a consensus target price of $14.00.
Check Out Our Latest Stock Analysis on PAYS
Paysign Company Profile
(
Get Free Report)
Paysign, Inc is a financial technology company that provides payment and financial services primarily to the healthcare and pharmaceutical industries. Its platform supports prepaid card programs, digital payments and other disbursement solutions designed to help organizations distribute funds to individuals efficiently and securely.
The company's services include patient assistance programs that help eligible patients receive financial support for prescription medications and other healthcare costs.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
